Category: News

Canadian Clusterbusters : time to unite

The worst pain of all Attacks of excruciating pain around the eye and temple, just on this one side. A hot poker pushed inside your face. Your eye tears, your nose runs. For an hour or two, you are in hell. The attack is brutal,…

Tips to keep your mental health for physicians…and everyone else!

Inspired from a document by the Psychiatrist Association of Quebec distributed to physicians. But hey, other people can benefit from good advice too!  Living during COVID-19 is not easy.  Depending on a person’s character, COVID related stressors, confinement settings, and other factors, different feelings can…

Ajovy (fremanezumab) approved by Health Canada

As of April 9th, Health Canada has approved Ajovy for use in Canada. This is great news for people living with migraine! ** ALWAYS discuss with your health care provider when making decisions about medications. What is Ajovy? Ajovy is a monoclonal antibody targeting CGRP….

CGRP antibody access and coverage in Canada in April 2020

CGRP antibodies are a new class of migraine preventives. (See this post). These drugs are more expensive than oral preventives. The cost charged to a patient includes the cost of the medication AND the pharmacy fees (variable from one pharmacy to the other). There are…

Another new drug for migraine is likely on its way to Canada.

A completely new type of migraine preventive medication has been developed over the last ten years, one which uses antibodies to stop migraine attacks.  These antibodies are similar to the ones that help you fight viruses, like the common cold, but they are made to…

Become a volunteer for the Canadian Migraine Tracker App

The objective: ensure a good communication with the users of the Canadian Migraine Tracker, an app for migraine monitoring developed by the Canadian Headache Society in collaboration with Migraine Canada.  This position is ideal if you wish to contribute to the migraine community and if…

CADTH supports the reimbursement of Botox for Chronic Migraine

Good News! CADTH supports the reimbursement of Botox for Chronic Migraine Botox was approved by Health Canada in 2011, but reimbursement by public payers was difficult to obtain. Following an updated recommendation from CADTH, access is likely to improve for Canadians with Chronic Migraine. What…

Will Aimovig be covered by public drug plans in Canada?

We have been following the arrival of CGRP antibodies (Aimovig, Emgality) in Canada. Below are a few comments on access and coverage. What is the drug coverage system like in Canada? Canadians pay their medications either through private insurance companies (with plans often linked with…

CGRP antibodies: practical details on access

  We need better options for migraine prevention. And, thanks to the persistent researchers who worked so hard on CGRP, we now have a new class of medications, CGRP antibodies. Below is a table of the drugs with the doses, the brand names, and the…